CoChat
Sign Up
Cited by 57

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Proteomic approaches to the study of papillomavirus-host interactions

White, Elizabeth A., Howley, Peter M.·2013·Virology
DOI 10.1016/j.virol.2012.09.046PMC PMC3522865
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.virol.2012.09.046

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Research works printed but not linked: 113

  1. Agrawal, 2011, Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1, Science, 333, 1154, 10.1126/science.1206923 · DOI
  2. Akgul, 2006, HPV-associated skin disease, J. Pathol., 208, 165, 10.1002/path.1893 · DOI
  3. Albert, 2002, Identification of a ubiquitin-protein ligase subunit within the CCR4-NOT transcription repressor complex, EMBO J., 21, 355, 10.1093/emboj/21.3.355 · DOI
  4. Ansari, 2012, Peptide interactions stabilize and restructure human papillomavirus type 16 E6 to interact with p53, J. Virol., 86, 11386, 10.1128/JVI.01236-12 · DOI
  5. Arron, 2011, Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma, J. Invest. Dermatol., 131, 1745, 10.1038/jid.2011.91 · DOI
  6. Behm-Ansmant, 2006, mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes, Genes Dev., 20, 1885, 10.1101/gad.1424106 · DOI
  7. Bernard, 2010, Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments, Virology, 401, 70, 10.1016/j.virol.2010.02.002 · DOI
  8. Besche, 2009, Isolation of mammalian 26S proteasomes and p97/VCP complexes using the ubiquitin-like domain from HHR23B reveals novel proteasome-associated proteins, Biochemistry, 48, 2538, 10.1021/bi802198q · DOI
  9. Braun, 2011, GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets, Mol. Cell., 44, 120, 10.1016/j.molcel.2011.09.007 · DOI
  10. Braun, 2012, History of protein-protein interactions: from egg-white to complex networks, Proteomics, 12, 1478, 10.1002/pmic.201100563 · DOI
  11. Braun, 2009, An experimentally derived confidence score for binary protein–protein interactions, Nat. Methods, 6, 91, 10.1038/nmeth.1281 · DOI
  12. Breitkreutz, 2010, A global protein kinase and phosphatase interaction network in yeast, Science, 328, 1043, 10.1126/science.1176495 · DOI
  13. Brimer, 2007, Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein, Virology, 358, 303, 10.1016/j.virol.2006.08.038 · DOI · Paper page
  14. Chekulaeva, 2011, miRNA repression involves GW182-mediated recruitment of CCR4-NOT through conserved W-containing motifs, Nat. Struct. Mol. Biol., 18, 1218, 10.1038/nsmb.2166 · DOI
  15. Chen, 1995, Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein, Science, 269, 529, 10.1126/science.7624774 · DOI · Paper page
  16. Choe, 1989, Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs, J. Virol., 63, 1743, 10.1128/jvi.63.4.1743-1755.1989 · DOI
  17. Choi, 2011, SAINT: probabilistic scoring of affinity purification-mass spectrometry data, Nat. Methods, 8, 70, 10.1038/nmeth.1541 · DOI · Paper page
  18. Coon, 2005, Tandem mass spectrometry for peptide and protein sequence analysis, Biotechniques, 38, 10.2144/05384TE01 · DOI
  19. de Villiers, 2004, Classification of papillomaviruses, Virology, 324, 17, 10.1016/j.virol.2004.03.033 · DOI
  20. DeMasi, 2005, Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding, Proc. Natl. Acad. Sci. U S A, 102, 11486, 10.1073/pnas.0505322102 · DOI · Paper page
  21. Dereeper, 2010, BLAST-EXPLORER helps you building datasets for phylogenetic analysis, BMC Evol. Biol., 10, 8, 10.1186/1471-2148-10-8 · DOI
  22. Dereeper, 2008, Phylogeny.fr: robust phylogenetic analysis for the non-specialist, Nucleic Acids Res., 36, W465, 10.1093/nar/gkn180 · DOI · Paper page
  23. Devgan, 2006, p21WAF1/Cip1 suppresses keratinocyte differentiation independently of the cell cycle through transcriptional up-regulation of the IGF-I gene, J. Biol. Chem., 281, 30463, 10.1074/jbc.M604684200 · DOI
  24. Dickson, 2000, Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics, Mol. Cell. Biol., 20, 1436, 10.1128/MCB.20.4.1436-1447.2000 · DOI · Paper page
  25. Doorbar, 1990, Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line, Virology, 178, 254, 10.1016/0042-6822(90)90401-C · DOI
  26. Dreze, 2010, High-quality binary interactome mapping, Methods Enzymol., 470, 281, 10.1016/S0076-6879(10)70012-4 · DOI
  27. Dyson, 1992, Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins, J. Virol., 66, 6893, 10.1128/jvi.66.12.6893-6902.1992 · DOI · Paper page
  28. Fabian, 2011, miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motifs that interact with CCR4-NOT, Nat. Struct. Mol. Biol., 18, 1211, 10.1038/nsmb.2149 · DOI · Paper page
  29. Fabian, 2009, Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation, Mol. Cell., 35, 868, 10.1016/j.molcel.2009.08.004 · DOI
  30. Feltkamp, 2008, Betapapillomaviruses: innocent bystanders or causes of skin cancer, J. Clin. Virol., 43, 353, 10.1016/j.jcv.2008.09.009 · DOI
  31. Fields, 1989, A novel genetic system to detect protein–protein interactions, Nature, 340, 245, 10.1038/340245a0 · DOI
  32. Garcia-Vallve, 2005, Papillomaviruses: different genes have different histories, Trends Microbiol., 13, 514, 10.1016/j.tim.2005.09.003 · DOI
  33. Gavin, 2006, Proteome survey reveals modularity of the yeast cell machinery, Nature, 440, 631, 10.1038/nature04532 · DOI
  34. Gillison, 2008, HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women, Cancer, 113, 3036, 10.1002/cncr.23764 · DOI
  35. Giot, 2003, A protein interaction map of Drosophila melanogaster, Science, 302, 1727, 10.1126/science.1090289 · DOI · Paper page
  36. Gottschling, 2011, Modular organizations of novel cetacean papillomaviruses, Mol. Phylogenet. Evol., 59, 34, 10.1016/j.ympev.2010.12.013 · DOI
  37. Gulbahce, 2012, Viral perturbations of host networks reflect disease etiology, PLoS Comput. Biol., 8, e1002531, 10.1371/journal.pcbi.1002531 · DOI
  38. Ho, 2002, Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry, Nature, 415, 180, 10.1038/415180a · DOI
  39. Howie, 2011, Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association, PLoS Pathog., 7, e1002211, 10.1371/journal.ppat.1002211 · DOI
  40. Howley, P.M., Lowy, D.R., 2006. Papillomaviruses. In: Knipe D.M., Howley P.M., Griffin D.E., Lamb R.A., Martin, B. Roizman M.A., Straus S.E. (Eds.) Fields Virology, fifth ed.
  41. Huang, 2012, YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14, Oncogene
  42. Huh, 2007, Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor, J. Virol., 81, 9737, 10.1128/JVI.00881-07 · DOI · Paper page
  43. Huh, 2005, Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600, Proc. Natl. Acad. Sci. U S A, 102, 11492, 10.1073/pnas.0505337102 · DOI · Paper page
  44. Ito, 2001, A comprehensive two-hybrid analysis to explore the yeast protein interactome, Proc. Natl. Acad. Sci. U S A, 98, 4569, 10.1073/pnas.061034498 · DOI · Paper page
  45. Ito, 2000, Toward a protein-protein interaction map of the budding yeast: A comprehensive system to examine two-hybrid interactions in all possible combinations between the yeast proteins, Proc. Natl. Acad. Sci. U S A, 97, 1143, 10.1073/pnas.97.3.1143 · DOI
  46. Jager, 2011, Purification and characterization of HIV-human protein complexes, Methods, 53, 13, 10.1016/j.ymeth.2010.08.007 · DOI
  47. Javier, 2011, Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses, J. Virol., 85, 11544, 10.1128/JVI.05410-11 · DOI · Paper page
  48. Kiyono, 1997, Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein, Proc. Natl. Acad. Sci. U S A, 94, 11612, 10.1073/pnas.94.21.11612 · DOI · Paper page
  49. Kleijnen, 2000, The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome, Mol. Cell., 6, 409, 10.1016/S1097-2765(00)00040-X · DOI
  50. Komarova, 2011, Proteomic analysis of virus–host interactions in an infectious context using recombinant viruses, Mol. Cell. Proteomics, 10, 10.1074/mcp.M110.007443 · DOI
  51. Kreimer, 2005, Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review, Cancer Epidemiol. Biomarkers Prev., 14, 467, 10.1158/1055-9965.EPI-04-0551 · DOI
  52. Krogan, 2006, Global landscape of protein complexes in the yeast Saccharomyces cerevisiae, Nature, 440, 637, 10.1038/nature04670 · DOI
  53. Kuhnle, 2011, Physical and functional interaction of the HECT ubiquitin-protein ligases E6AP and HERC2, J. Biol. Chem., 286, 19410, 10.1074/jbc.M110.205211 · DOI
  54. Lace, 2008, The E8–E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes, J. Virol., 82, 10841, 10.1128/JVI.01481-08 · DOI
  55. Lambert, 2012, Mapping physical interactions within chromatin by proteomic approaches, Proteomics, 12, 1609, 10.1002/pmic.201100547 · DOI
  56. Lane, 1979, T antigen is bound to a host protein in SV40-transformed cells, Nature, 278, 261, 10.1038/278261a0 · DOI
  57. Lazic, 2012, Human papillomavirus type 8 e6 oncoprotein inhibits transcription of the PDZ protein syntenin-2, J. Virol., 86, 7943, 10.1128/JVI.00132-12 · DOI
  58. Lievens, 2009, Mammalian two-hybrids come of age, Trends Biochem. Sci., 34, 579, 10.1016/j.tibs.2009.06.009 · DOI
  59. Linzer, 1979, Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells, Cell, 17, 43, 10.1016/0092-8674(79)90293-9 · DOI
  60. Liu, X., Yang, N., Figel, S.A., Wilson, K.E., Morrison, C.D., Gelman, I.H., and Zhang, J. (2012). PTPN14 interacts with and negatively regulates the oncogenic function of YAP. Oncogene. · DOI · Paper page
  61. Liu, 1999, Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells, J. Virol., 73, 7297, 10.1128/JVI.73.9.7297-7307.1999 · DOI · Paper page
  62. Lowy, 2008, Human papillomavirus infection and the primary and secondary prevention of cervical cancer, Cancer, 113, 1980, 10.1002/cncr.23704 · DOI
  63. Martinez-Noel, 2012, Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes, Mol. Cell. Biol., 32, 3095, 10.1128/MCB.00201-12 · DOI
  64. McElhinny, 2008, Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways, Oncogene, 27, 5138, 10.1038/onc.2008.228 · DOI
  65. McLaughlin-Drubin, 2008, Human papillomavirus type 16 E7 oncoprotein associates with E2F6, J. Virol., 82, 8695, 10.1128/JVI.00579-08 · DOI · Paper page
  66. McPhillips, 2006, Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses, J. Virol., 80, 9530, 10.1128/JVI.01105-06 · DOI
  67. Mengual-Chulia, B., Garcia-Perez, R., Gottschling, M., Nindl, I., and Bravo, I.G. (2012). Novel animal papillomavirus sequences and accurate phylogenetic placement. Mol. Phylogenet Evol. · DOI
  68. Muller, 2012, Large scale genotype comparison of human papillomavirus e2–host interaction networks provides new insights for e2 molecular functions, PLoS Pathog., 8, e1002761, 10.1371/journal.ppat.1002761 · DOI
  69. Munger, 1989, Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product, EMBO. J., 8, 4099, 10.1002/j.1460-2075.1989.tb08594.x · DOI · Paper page
  70. Nesvizhskii, 2012, Computational and informatics strategies for identification of specific protein interaction partners in affinity purification mass spectrometry experiments, Proteomics, 12, 1639, 10.1002/pmic.201100537 · DOI
  71. Nguyen, 2006, Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation, Genes. Dev., 20, 1028, 10.1101/gad.1406006 · DOI
  72. Oswald, 2001, p300 acts as a transcriptional coactivator for mammalian Notch-1, Mol. Cell. Biol., 21, 7761, 10.1128/MCB.21.22.7761-7774.2001 · DOI
  73. Patel, 1999, The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300, EMBO J., 18, 5061, 10.1093/emboj/18.18.5061 · DOI · Paper page
  74. Patterson, 2003, Proteomics: the first decade and beyond, Nat. Genet., 33, 311, 10.1038/ng1106 · DOI
  75. Powell, 2010, NCoR1 mediates papillomavirus E8;E2C transcriptional repression, J. Virol., 84, 4451, 10.1128/JVI.02390-09 · DOI
  76. Rangarajan, 2001, Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation, EMBO J., 20, 3427, 10.1093/emboj/20.13.3427 · DOI
  77. Restivo, 2011, IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes, EMBO J., 30, 4571, 10.1038/emboj.2011.325 · DOI
  78. Rotenberg, 1989, Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction, Virology, 172, 489, 10.1016/0042-6822(89)90191-8 · DOI
  79. Salsman, 2012, Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair response, J. Virol., 86, 806, 10.1128/JVI.05442-11 · DOI
  80. Sardiu, 2008, Probabilistic assembly of human protein interaction networks from label-free quantitative proteomics, Proc. Natl. Acad. Sci. U S A, 105, 1454, 10.1073/pnas.0706983105 · DOI · Paper page
  81. Sardiu, 2009, Determining protein complex connectivity using a probabilistic deletion network derived from quantitative proteomics, PLoS One, 4, e7310, 10.1371/journal.pone.0007310 · DOI
  82. Sardiu, 2011, Building protein–protein interaction networks with proteomics and informatics tools, J. Biol. Chem., 286, 23645, 10.1074/jbc.R110.174052 · DOI
  83. Scanlon, 2009, Isolation of human proteasomes and putative proteasome-interacting proteins using a novel affinity chromatography method, Exp. Cell Res., 315, 176, 10.1016/j.yexcr.2008.10.027 · DOI
  84. Scheffner, 1990, The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53, Cell, 63, 1129, 10.1016/0092-8674(90)90409-8 · DOI · Paper page
  85. Schiffman, 2007, Human papillomavirus and cervical cancer, Lancet, 370, 890, 10.1016/S0140-6736(07)61416-0 · DOI
  86. Sedman, 1991, The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture, J. Virol., 65, 4860, 10.1128/jvi.65.9.4860-4866.1991 · DOI
  87. Shapira, 2009, A physical and regulatory map of host–influenza interactions reveals pathways in H1N1 infection, Cell, 139, 1255, 10.1016/j.cell.2009.12.018 · DOI
  88. Sowa, 2009, Defining the human deubiquitinating enzyme interaction landscape, Cell, 138, 389, 10.1016/j.cell.2009.04.042 · DOI
  89. Stransky, 2011, The mutational landscape of head and neck squamous cell carcinoma, Science, 333, 1157, 10.1126/science.1208130 · DOI
  90. Stubenrauch, 2000, The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes, J. Virol., 74, 1178, 10.1128/JVI.74.3.1178-1186.2000 · DOI
  91. Stubenrauch, 2007, The E8 repression domain can replace the E2 transactivation domain for growth inhibition of HeLa cells by papillomavirus E2 proteins, Int. J. Cancer, 121, 2284, 10.1002/ijc.22907 · DOI
  92. Stubenrauch, 2001, The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31, J. Virol., 75, 4139, 10.1128/JVI.75.9.4139-4149.2001 · DOI
  93. Tai, 2010, Characterization of the brain 26S proteasome and its interacting proteins, Front Mol. Neurosci., 3, 12
  94. Tasaki, 2005, A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons, Mol. Cell Biol., 25, 7120, 10.1128/MCB.25.16.7120-7136.2005 · DOI
  95. Tasaki, 2009, The substrate recognition domains of the N-end rule pathway, J. Biol. Chem., 284, 1884, 10.1074/jbc.M803641200 · DOI · Paper page
  96. Thomas, 2005, E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation, Mol. Cell, 17, 251, 10.1016/j.molcel.2004.12.016 · DOI · Paper page
  97. Trinkle-Mulcahy, 2008, Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes, J. Cell Biol., 183, 223, 10.1083/jcb.200805092 · DOI
  98. Uetz, 2000, A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae, Nature, 403, 623, 10.1038/35001009 · DOI · Paper page
  99. van Doorslaer, K., Tan, Q., Xirasagar, S., Bandaru, S., Gopalan, V., Mohamoud, Y., Huyen, Y. McBride, A.A. The papillomavirus episteme: a central resource for papillomavirus sequence data and analysis. Nucleic Acids Research, in press.
  100. Vos, 2009, The ubiquitin-specific peptidase USP15 regulates human papillomavirus type 16 E6 protein stability, J. Virol., 83, 8885, 10.1128/JVI.00605-09 · DOI
  101. Walhout, 2000, Protein interaction mapping in C. elegans using proteins involved in vulval development, Science, 287, 116, 10.1126/science.287.5450.116 · DOI
  102. Wang, 1995, Hypoxia-inducible factor 1 is a basic-helix–loop-helix-PAS heterodimer regulated by cellular O2 tension, Proc. Natl. Acad. Sci. U.S.A., 92, 5510, 10.1073/pnas.92.12.5510 · DOI · Paper page
  103. Watson, 2008, Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods, Cancer, 113, 2841, 10.1002/cncr.23758 · DOI
  104. Werness, 1990, Association of human papillomavirus types 16 and 18 E6 proteins with p53, Science, 248, 76, 10.1126/science.2157286 · DOI · Paper page
  105. White, E.A., Kramer, R.E., Tan, M.J., Hayes, S.D., Harper, J.W., Howley, P.M., 2012b. Comprehensive analysis of host cellular interactions with human papilloma virus E6 proteins identifies new E6 binding partners and reflects viral diversity. J. Virol. 86, published ahead of print 26 September 2012, 101128/JVI.02172-12. · DOI · Paper page
  106. Whyte, 1988, Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product, Nature, 334, 124, 10.1038/334124a0 · DOI · Paper page
  107. Wilm, 1996, Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry, Nature, 379, 466, 10.1038/379466a0 · DOI
  108. Wu, 2004, Modulation of Notch signaling by mastermind-like (MAML) transcriptional co-activators and their involvement in tumorigenesis, Semin. Cancer Biol., 14, 348, 10.1016/j.semcancer.2004.04.014 · DOI
  109. You, 2004, Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes, Cell, 117, 349, 10.1016/S0092-8674(04)00402-7 · DOI
  110. Zhou, 2010, Online nanoflow RP-RP-MS reveals dynamics of multicomponent Ku complex in response to DNA damage, J. Proteome Res., 9, 6242, 10.1021/pr1004696 · DOI
  111. Zimmermann, 1999, The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300, J. Virol., 73, 6209, 10.1128/JVI.73.8.6209-6219.1999 · DOI · Paper page
  112. Zobel, 2003, The papillomavirus E8-E2C protein represses DNA replication from extrachromosomal origins, Mol. Cell Biol., 23, 8352, 10.1128/MCB.23.22.8352-8362.2003 · DOI
  113. Zybailov, 2006, Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae, J. Proteome Res., 5, 2339, 10.1021/pr060161n · DOI

Cited by

Metadata

Authors
White, E. A., & Howley, P. M.
Venue
Virology
Publisher
Elsevier BV
Published
2013-01
Volume
435
Issue
1
Pages
57-69
ISSN
0042-6822
DOI
10.1016/j.virol.2012.09.046
PMC
PMC3522865
Cited by
57
References
21
Language
en
Licence
Funders
NIH to PMH (1RC1 CA145188, P01 CA50661)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review